Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Deeks

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|July 9, 2024
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimodMohamed Abdel-Mohsen, Steven Deeks, Leila Giron, et al.
Nature Microbiology|June 17, 2020
FOXO1 promotes HIV latency by suppressing ER stress in T cellsAlbert Vallejo-Gracia, Irene P Chen, Rosalba Perrone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future ResearchSavita Pahwa, Steven Deeks, Shimian Zou, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
AIDS Research and Human Retroviruses|January 21, 2021
Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker StudyKaren L Diepstra, Liz Barr, David Palm, et al.
AIDS Research and Human Retroviruses|August 28, 2020
The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and AgingStephanie Shiau, Alexis A Bender, Jane A O'Halloran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
Time to Viral Rebound After Interruption of Modern Antiretroviral TherapiesJonathan Z Li, Evgenia Aga, Ronald J Bosch, et al.
The Journal of Infectious Diseases|June 5, 2020
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral TherapyNikolaus Jilg, Pilar Garcia-Broncano, Michael Peluso, et al.
Plos Pathogens|October 13, 2020
Mining for humoral correlates of HIV control and latent reservoir sizeJishnu Das, Anush Devadhasan, Caitlyn Linde, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|July 9, 2024
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimodMohamed Abdel-Mohsen, Steven Deeks, Leila Giron, et al.
Nature Microbiology|June 17, 2020
FOXO1 promotes HIV latency by suppressing ER stress in T cellsAlbert Vallejo-Gracia, Irene P Chen, Rosalba Perrone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future ResearchSavita Pahwa, Steven Deeks, Shimian Zou, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
AIDS Research and Human Retroviruses|January 21, 2021
Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker StudyKaren L Diepstra, Liz Barr, David Palm, et al.
AIDS Research and Human Retroviruses|August 28, 2020
The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and AgingStephanie Shiau, Alexis A Bender, Jane A O'Halloran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
Time to Viral Rebound After Interruption of Modern Antiretroviral TherapiesJonathan Z Li, Evgenia Aga, Ronald J Bosch, et al.
The Journal of Infectious Diseases|June 5, 2020
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral TherapyNikolaus Jilg, Pilar Garcia-Broncano, Michael Peluso, et al.
Plos Pathogens|October 13, 2020
Mining for humoral correlates of HIV control and latent reservoir sizeJishnu Das, Anush Devadhasan, Caitlyn Linde, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
Pageof 5